ClinicalTrials.govpublic full text
Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults
human immunodeficiency virus prevention, human immunodeficiency virus (hiv), human immunodeficiency virus, immune response, neutralizing antibodies, hiv prevention, cellular immunogenicity, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871319
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.